Clinical Trials Directory

Trials / Completed

CompletedNCT02142985

Respiratory Variation in Central Venous Oxygen Saturation Predicts Volume Responsiveness in Hemodynamically Unstable Patients Under Mechanical Ventilation : a Prospective Cohort Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Vascular filling is the main treatment of hypovolemia. Hypovolemia diagnosis can be difficult in some situations and need to be confirmed with other investigations. Venous oxymetry based on the ScvO2 values represent a valuable way to predict responsivness to fluid filling maneuver in patients with hemodynamic instability.

Detailed description

Vascular filling represent the milestone of the treatment of hypovolemia. Its main objective is to restore vascular volume and correct perfusion issues preventing the deleterious consequences of prolonged shock. Hypovolemia diagnosis is easy to made in obvious clinical situations such as hemorrhagic shock, deshydratation..., but there still many diagnostic difficulties regarding latent hypovolemia especially if associated with left ventricular dysfunction. In this situations, diagnostic of hypovolemia is hard to made and other investigations are needed. Central venous pressure (CVP) and pulmonary occlusion artery pressure (PAPO) are the mainly used parameters for indicating vascular filling but actually many studies underline their low liability in this situation. After vascular filling, outcome measurment is needed to evaluate the efficacity of the treatment. Outcome measurment based on hemodynamic criteria is still insufficient. In fact, tissue hypoxia persists if the cardio - respiratory system did not adapt to the metabolic needs, that's why a pathway based on therapeutic objectives like venous oxymetry is needed. Theorically, a filling maneuver is beneficial if associated with a ScvO2 amelioration. It reflects the amelioration of cardiac output and predicts the positive responsivness to the filling test.

Conditions

Interventions

TypeNameDescription
DRUGSodium Chloride 0.9% Intravenousvascular filling with 500 ml of crystalloid solution (sodium chloride 0.9%) over 30 minutes

Timeline

Start date
2014-04-01
Primary completion
2015-04-01
Completion
2015-10-01
First posted
2014-05-20
Last updated
2021-05-05

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT02142985. Inclusion in this directory is not an endorsement.